Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 8.9.2026Laboratoires Besins International (LBE)76921UTROGESTAN (cps mol 30x100 mg (blister))14.9.2026R
 8.9.2026Teva B.V. (TEV-NL-4)1626CEzetimib/simvastatín Teva B.V. 10 mg/40 mg (tbl 30x10 mg/40 mg (blis.OPA/Al/PVC/Al))7.9.2026O
 8.9.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3381AEplerenone Teva 50 mg (tbl flm 30x1x50 mg (blis.PVC/PVDC/Al perf.))7.9.2026O
 8.9.2026Theramex Ireland Limited (THX)09736Zoely 2,5 mg/1,5 mg filmom obalené tablety (tbl flm 28(24 akt.+4 placebo)x2,5 mg/1,5 mg (blis.PVC/Al))8.9.2026R
 8.9.2026STADA Arzneimittel AG (STD)7308ENilotinib STADA 200 mg tvrdé kapsuly (cps dur 112 (4x28)x200 mg (blis.PVC/PE/PVDC/Al)-multibal.)30.9.2026Z
 8.9.2026STADA Arzneimittel AG (STD)4222ELosartan/Hydrochlorothiazide STADA Arzneimittel 100 mg/25 mg (tbl flm 98x100 mg/25 mg (blis.PVC/PE/PVDC/Al))30.9.2026Z
 8.9.2026STADA Arzneimittel AG (STD)35064Melyd 3 mg tablety (tbl 30x3 mg (blis.PVC/Al))30.9.2026Z
 8.9.2026STADA Arzneimittel AG (STD)3646ELosartan STADA Arzneimittel 50 mg filmom obalené tablety (tbl flm 30x50 mg (blis.PVC/PE/PVDC/Al))30.9.2026Z
 8.9.2026STADA Arzneimittel AG (STD)35066Melyd 3 mg tablety (tbl 60x3 mg (blis.PVC/Al))30.9.2026Z
 8.9.2026STADA Arzneimittel AG (STD)3648ELosartan STADA Arzneimittel 50 mg filmom obalené tablety (tbl flm 90x50 mg (blis.PVC/PE/PVDC/Al))30.9.2026Z
 8.9.2026STADA Arzneimittel AG (STD)0446FEdoxabán STADA 30 mg filmom obalené tablety (tbl flm 30x30 mg (blis. PVC/Al))30.9.2026Z
 7.9.2026OMEGA PHARMA a.s. (OMG-1)0387ECOLDREX MAXGRIP LEMON (plo por 14 (vre.papier/PE/Al/EMAA))19.10.2026R
 7.9.2026Medreg s.r.o. (MRG-3)9449EPregabalin Medreg 150 mg (cps dur 56x150 mg (blis.PVC-PVDC/Al))4.9.2026U
 7.9.2026Medreg s.r.o. (MRG-3)9439EPregabalin Medreg 75 mg (cps dur 56x75 mg (blis.PVC-PVDC/Al))4.9.2026U
 6.9.2026Teva B.V. (TEV-NL-4)8887EFerric carboxymaltose Teva 50 mg železa/ml injekčná/infúzna disperzia (dis ijf 1x10 ml/500 mg (liek.inj.skl.))3.9.2026O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To